��

Spero Therapeutics

2 followers

‌

Spero Therapeutics (Nasdaq: SPRO) is a multi-asset pre-commercial stage biopharmaceutical company in Cambridge, Mass. We are highly committed to advancing novel treatment approaches for bacterial infections with a world-class team of biotechnological and biopharmaceutical experts. The company has a... Read more

Industries

Headquarters

Cambridge, United States

Employees

Links

Org chart

President & CEO

Sath Shukla

Collapse

Esther Rajavelu

CFO & Chief Business Officer

Chief Medical Officer

Timothy Keutzer

Chief Operating Officer, Spero Therapeutics

Chief Human Resources Officer

Chief Scientific Officer

Jay Blackington

VP, People Strategy & Culture

Vice President, Alliance Management And Business Development

Vice President / Head Of Quality Assurance At Spero Therapeutics

Executive Director, Head Of Clinical Pharmacology, DMPK And Drug Analysis

Senior Director

John C. Pottage

Director

Director

Tregoning Prior

Director

Frank E. Thomas

Director

Director, Biostatistics & Statistical Programming

Director, CMC

Myriah Satterfield

Director, Clinical Data Management

Senior Executive Assistant

Director, Clinical Operations

Teams

Leadership Team

4 members

Directors Team

11 members

Clinical and Research Operations

7 members

Business Development & Market Access

1 members

Operations Team

4 members

Management Team

4 members

Similar companies

Kura Oncology

19 followers

REVOLUTION Medicines

5 followers

Halozyme Therapeutics

4 followers

C4 Therapeutics

4 followers

Stemline Therapeutics

3 followers

4D Molecular Therapeutics

3 followers

Tenaya Therapeutics

2 followers

Viridian Therapeutics

2 followers

Embark Veterinary

1 follower

Dragonfly Therapeutics

1 follower

Aspen Neuroscience

1 follower

Explore companies